Sortica, V. A., Lindenau, J. D., Cunha, M. G., Ohnishi, M. D. O., Ventura, A. M. R. d. S., Ribeiro-dos-Santos, ?. K. C., . . . Hutz, M. H. (2017). SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria. Future Medicine.
Citação Padrão ChicagoSortica, Vinicius Albuquerque, Juliana D. Lindenau, Maristela G. Cunha, Maria Deise O. Ohnishi, Ana Maria Revoredo da Silva Ventura, ?ndrea K. C. Ribeiro-dos-Santos, Sidney E. B. Santos, Luciano S. P. Guimar?es, and Mara H. Hutz. SLCO1A2, SLCO1B1 and SLCO2B1 Polymorphisms Influences Chloroquine and Primaquine Treatment in Plasmodium Vivax Malaria. Future Medicine, 2017.
Citação MLASortica, Vinicius Albuquerque, et al. SLCO1A2, SLCO1B1 and SLCO2B1 Polymorphisms Influences Chloroquine and Primaquine Treatment in Plasmodium Vivax Malaria. Future Medicine, 2017.